Detailed evaluation of different <scp><sup>68</sup>Ge/<sup>68</sup>Ga</scp> generators: an attempt toward achieving efficient <scp><sup>68</sup>Ga</scp> radiopharmacyRubel Chakravarty, Ashutosh Dash, Priya Bhusari et al.|Journal of Labelled Compounds and Radiopharmaceuticals|2016Cited by 38
Evaluating the potential of kit-based 68Ga-ubiquicidin formulation in diagnosis of infectionPriya Bhusari, Jaya Shukla, Apurva Sood et al.|Nuclear Medicine Communications|2018Cited by 19
Integrin α <sub>v</sub> β <sub>3</sub> as a Promising Target to Image Neoangiogenesis Using In-House Generator-Produced Positron Emitter <sup>68</sup> Ga-Labeled DOTA-Arginine-Glycine-Aspartic Acid (RGD) LigandRakhee Vatsa, Bhagwant Rai Mittal, Priya Bhusari et al.|Cancer Biotherapy and Radiopharmaceuticals|2015Cited by 13
Toward realization of ‘mix-and-use’ approach in 68 Ga radiopharmacy: preparation, evaluation and preliminary clinical utilization of 68 Ga-labeled NODAGA-coupled RGD peptide derivativeSudipta Chakraborty, Ashutosh Dash, Rubel Chakravarty et al.|Nuclear Medicine and Biology|2015Cited by 11
Effect of Macro-Cyclic Bifunctional Chelators DOTA and NODAGA on Radiolabeling and <i>In Vivo</i> Biodistribution of Ga-68 Cyclic RGD DimerRakhee Vatsa, Bhagwant Rai Mittal, Ashutosh Dash et al.|Cancer Biotherapy and Radiopharmaceuticals|2019Cited by 9